Treatment of Locally Advanced NSCLC with Chemo-radiotherapy


The aim of this evaluation form is to gain your feedback, in order to maintain high educational standards and provide a reference for continuous improvement. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did this E-Learning module provide state-of-the art in the treatment of locally-advanced non-small cell lung cancer (NSCLC) with chemo-radiotherapy? (1: no, not at all; 5: yes, absolutely)

2. Did this E-Learning module discuss in depth strategies of association of chemotherapy and radiotherapy, data from clinical trials, outcomes and toxicity profiles? (1: no, not at all; 5: yes, absolutely)

3. Did this E-Learning module provide an update on recent data in the field of locally-advanced NSCLC in terms of radiotherapy techniques and medical treatments illustrated with findings from clinical studies and enabling clinical uptake? (1: no, not at all; 5: yes, absolutely)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-absolutely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. Do you think that the scientific content of this E-learning activity contains any commercial material?

9. If you answered YES, please motivate your choice in the box below:

10. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: